|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/37 | (2006.01) |
| G01N 33/569 | (2006.01) | ||
| G01N 33/573 | (2006.01) |
| (11) | Patento numeris | 3279335 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17178062.0 |
| Europos patento paraiškos padavimo data | 2012-12-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-02-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-03-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161582339 P | 2011-12-31 | US |
| (72) |
Wang, Joanne, US
Dixit, Anuradha, US
Abel, Kenton, US
Gupta, Swati, US
Fernandez-Salas, Ester, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | HIGHLY SENSITIVE CELL-BASED ASSAY TO DETECT THE PRESENCE OF ACTIVE BOTULINUM NEUROTOXIN SEROTYPE-A |
| HIGHLY SENSITIVE CELL-BASED ASSAY TO DETECT THE PRESENCE OF ACTIVE BOTULINUM NEUROTOXIN SEROTYPE-A |